BBS7 Antikörper (AA 263-510)
Kurzübersicht für BBS7 Antikörper (AA 263-510) (ABIN1886284)
Target
Alle BBS7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 263-510
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein fragment contain a sequence corresponding to a region within amino acids 263 and 510 of Human BBS7
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- BBS7 (Bardet-Biedl Syndrome 7 (BBS7))
-
Andere Bezeichnung
- BBS7
-
Hintergrund
-
Mutations in this gene have been observed in patients with Bardet-Biedl syndrome type 7.The encoded protein may play a role in eye, limb, cardiac and reproductive system development.Two transcript variants encoding distinct isoforms have been identified for this gene.[provided by RefSeq]
-
Molekulargewicht
- 80 kDa
-
Gen-ID
- 55212
-
NCBI Accession
- NP_789794, NM_176824
-
Pathways
- Hedgehog Signalweg
Target
-